Form 8-K - Current report:
SEC Accession No. 0001641172-25-015342
Filing Date
2025-06-17
Accepted
2025-06-17 08:10:36
Documents
14
Period of Report
2025-05-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38579
2 EX-99.1 ex99-1.htm EX-99.1 25428
3 GRAPHIC ex99-1_001.jpg GRAPHIC 12855
  Complete submission text file 0001641172-25-015342.txt   253659

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aztr-20250513.xsd EX-101.SCH 3017
5 XBRL LABEL FILE aztr-20250513_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE aztr-20250513_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3668
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 251051905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)